Podcasts about 280e

Cannabis may finally be getting a new address in federal law.In this episode of The Stoner Budeez Podcast, Brian, Bean, and Gary break down one of the biggest developments in cannabis history: the proposed federal rescheduling of cannabis from Schedule I to Schedule III.What does it actually mean? Will it make cannabis legal nationwide? How could it impact dispensaries, taxes, banking, medical research, and the future of the industry? The Budeez cut through the headlines and explain what this historic move could mean for consumers, businesses, and the cannabis community as a whole.Along the way, the crew dives into the controversial 280E tax code, expanded opportunities for medical research, potential banking reforms, and why many industry experts believe this could be the beginning of a major shift in federal cannabis policy.As always, the conversation is powered by great flower, plenty of laughs, and a healthy dose of Budeez-style commentary.Topics Include:

Cannabis banking is complex, highly regulated, and full of opportunity. In this episode, Kristin Stowe of Credit Union 1 shares what it really takes to serve this underserved industry—from compliance and operational challenges to pricing and long-term strategy.We cover key differences from traditional banking, why starting with deposits matters, and what's ahead as the industry evolves. Whether you're exploring cannabis banking or refining your approach, this episode offers practical, real-world insight.Send us Fan MailPresented by Remedy ConsultingFor more information on BankTalk:BankTalk  WebsiteSubscribe to BankTalk NewsRemedy Consulting WebsiteRemedy LinkedInTo speak on the BankTalk Podcast, please  email us. 

Send us Fan MailThis week, as the summer starts, the federal government escalated its actions against the cannabis industry on multiple fronts, signaling a new era of enforcement and compliance pressure. We break down the "Federal War" that is separating the legal operators from the illicit market, and what the rapid pace of change—from rescheduling to tax clawbacks—means for every business and consumer in the cannabis space.1Here's what we cover in this educational episode on cannabis law, policy, and business:The 280E Tax Clawback: The DOJ files the first-ever lawsuit to claw back an $8.3 million 280E refund from MSO TerrAscend, sending a clear warning shot to all operators who have filed for refunds.1DEA's "Operation Weed Out": Federal task forces are turning hard toward the unlicensed market, with DEA-led raids shutting down illegal dispensaries in New York. The throughline: the line between who gets a buildout and who gets a raid is a state license.1The DEA's Rescheduling Showdown: The comment window for the expedited Schedule III hearing closes this week, and we discuss the urgency for industry participation and what a full plant reschedule means for 280E and research.1Virginia's Legalization Stalls: Governor Spanberger vetoes the adult-use market bill again, five years after possession was legalized, leaving the illicit market to thrive and eat up potential state revenue.1The TSA Policy Change: The Transportation Security Administration quietly updates its 'What Can I Bring?' page regarding medical marijuana, reflecting the DEA's Schedule III reclassification and the ripple effect on everyday life.1Cannabis Safety for Seniors: Stanford Medicine experts lay out 5 crucial risks older adults must consider, especially as a federal judge clears the path for Medicare's hemp/CBD coverage pilot.1The Rogue Crime Lab: In Illinois, a flawed THC testing method at a crime lab led to a marijuana DUI case being dropped, tainting over 2,000 cases nationally and challenging the reliability of per se THC DUI limits.1Final Thought: The contrast between the federal "gas pedal" and the state "brake" is the whole show. Rescheduling is prospective and uneven, rewarding the operators who built on compliance instead of loopholes. The winners in 2026 are the ones reading the fine print.1LINKS & RESOURCESNewsletter (free, spicy, actually useful): bit.ly/3VEn9vu1Sponsor — Collateral Base: bit.ly/m/collateral-base1Sponsor — Howard Law Group (Cannabis Industry Lawyer): [cannabis industry lawyer dot com](http://cannabis industry lawyer dot com)1Merch Store: spreadshop-admin.spreadshirt.com/Legalization-News-merch/all1Support the showGet our newsletter: https://bit.ly/3VEn9vu

Cole Preston is joined by Brad Spirrison to preview the upcoming Midwest Cannabis Forum, a regional event bringing together voices from across the cannabis, hemp, beverage, tech, finance, and regulatory worlds. The conversation explores why organizers are trying to create a space for dialogue between industries that are often at odds, while also discussing the rapidly changing landscape surrounding hemp-derived products, intoxicating beverages, and cannabis regulation in Illinois and beyond. They also discuss Illinois cannabis legislation, potential Schedule III implications, 280E tax relief, social equity concerns, medical dispensary access, and the broader uncertainty surrounding federal reform. Along the way, the episode features audience questions, Midwest market analysis, and plenty of classic Cole Memo banter. Watch video version and read full show notes here: https://thecolememo.com/2026/05/22/e281/

Send us Fan MailThe hosts discuss their Illinois dispensary passing its regulatory inspection on the first attempt, share examples of required compliance fixes (signage, plexiglass barriers, door relocation, and added redundant cameras), and describe setting up a punch-card rewards program integrated with Dutchie to prevent fraud while aiming for a smaller, fresher menu. They cover a DEA registration portal expansion limited to medical license holders and debate a “self-certifying medical use” approach as federal Schedule III efforts progress, including House action to allow VA doctors to recommend medical marijuana to veterans. Additional updates include Georgia's Patients First Act expanding qualifying conditions and changing caps, Arkansas tax implications tied to 280E, Susan Collins urging FBI help with illegal Maine grow houses, hemp beverage retail trends, ATF form wording on medical marijuana, a BEA memo on tracking illegal activity alongside legal markets, and a rundown of popular U.S. cannabis strains.Support the showGet our newsletter: https://bit.ly/3VEn9vu

In this episode:  2026 Tax Legislation Outlook — No major tax changes expected this year; budget reconciliation and new proposals remain largely on hold. Retirement Savings Updates — Expanded 401(k) investment options (real estate, private equity), new IRA access for those without workplace plans, and spousal IRA contribution rules. Roth IRA Benefits — Tax-free growth advantages and AGI threshold increases for contributions. Summer Tax Tips for Families — Tax withholding rules for dependent children working summer jobs, and how to hire your child if you're self-employed to reduce payroll taxes. Child and Dependent Care Credit — Enhanced credit limits for 2026, including eligibility for summer camps. Kids' Roth IRAs — Opening retirement accounts for children with earned summer income. Employee Fringe Benefits — IRS guidance on taxable vs. non-taxable benefits, including employer-paid tuition assistance (up to $5,250 annually, indexed for inflation starting 2027). Marijuana Tax Developments — Medical marijuana reclassified to Schedule III, removing the 280E deduction limitation for medical operators. Nonprofit Filing Deadline — May 15th deadline for calendar-year exempt organizations; upcoming Form 990 revisions for increased transparency. Tax Rates for High Earners — Breakdown of effective tax rates vs. tax brackets for top 1% earners, including capital gains and net investment income tax.

As the federal government moves toward rescheduling marijuana, the cannabis industry is eyeing a massive financial shift: the potential for $15 billion in retroactive tax relief from Section 280E. While the transition to Schedule 3 offers a path to future profitability, businesses must act immediately to file protective claims before statutes of limitation expire.This economic evolution coincides with a significant demographic pivot, as older adults become the fastest-growing consumer group, frequently choosing edibles for pain and sleep management over pharmaceuticals.However, the move toward higher-potency THC products is a double-edged sword, with new studies linking high-strength medicinal cannabis to increased risks of anxiety and psychiatric side effects, underscoring the need for careful regulation and informed medical guidance.Advertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

Cole Preston is joined by Michael Lasley of Illinois News Joint for a wide-ranging conversation about the federal government's latest cannabis rescheduling developments and what they could mean for Illinois. From Schedule III and 280E tax relief to homegrow protections, interstate commerce, and the future of medical cannabis, the two unpack the massive questions still hanging over the industry. They also discuss Illinois' unique dual-license structure, whether adult-use dispensaries could eventually become medical, how federal policy is increasingly driven by business interests, and why both believe cannabis is still in the very early stages of legalization. Along the way, they dive into craft cannabis, industry consolidation, homegrow culture, hemp enforcement, amusement parks, and the long history of cannabis in Champaign-Urbana. Watch video version and read full show notes here: https://thecolememo.com/2026/05/05/e277/

The potential move to Schedule III presents a massive financial opportunity for "Sin City," yet current local friction threatens to stall that momentum. As the federal government nears reclassification, the industry is at a crossroads between record-breaking growth and a cooling tourist market.While the city is built on "cashing in," Las Vegas could be losing tourists due to a recent crackdown on public consumption and strict enforcement. For the city to fully capitalize on the "Green Rush," it must reconcile its status as a global playground with the reality of a regulated cannabis market. If tourists feel penalized for legal use, they may take their gambling and entertainment dollars elsewhere.The shift to Schedule III is the "jackpot" many operators have been waiting for, primarily due to the removal of the 280E tax penalty. This change would allow businesses to finally treat cannabis like a standard industry, potentially injecting millions back into the local economy.Advertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

In this episode of the Cannabis Accounting Podcast, Andrew Hunzicker, CPA, founder and CEO of DOPE CFO, recaps the biggest cannabis industry news from April 2026.Listen to learn about:✅ The historic rescheduling of cannabis to Schedule III: what the April 23rd DOJ order means and why it's the most significant federal development in 15 years✅ The end of 280E: how Schedule III eliminates one of the most punishing tax laws in cannabis and what it means overnight for client financials✅ The DEA registration portal: what it is, why the first 60 days are critical, and what cannabis businesses need to do right now✅ Hemp, the Farm Bill, and the state-level battles shaping the industry heading into the midterms✅ What's coming next: the More Act, full descheduling, banking reform, and the wave of new cannabis companies expected to enter the marketArticles mentioned in the episode:https://mjbizdaily.com/news/can-the-28-billion-hemp-industry-be-saved/615123/https://www.marijuanamoment.net/virginia-governor-wants-amendments-to-marijuana-sales-legalization-bill-including-delayed-market-launch/https://ganjapreneur.com/ohio-judge-blocks-state-from-enforcing-thc-beverage-ban/https://mjbizdaily.com/news/meet-the-native-tribe-taking-on-the-most-anti-cannabis-state-in-the-us/615150/https://vicentellp.com/press/landmark-colorado-bill-introduced-to-modernize-colorado-thc-drinks-sales/https://ganjapreneur.com/massachusetts-cannabis-regulators-pass-cultivation-licensing-freeze/https://vicentellp.com/press/president-trump-signs-executive-order-accelerating-psychedelic-research-and-patient-access/https://ganjapreneur.com/massachusetts-gov-signs-cannabis-industry-updates-into-law/https://www.marijuanamoment.net/teen-marijuana-use-is-lower-now-than-before-legalization-government-study-from-minnesota-officials-shows/https://www.marijuanamoment.net/congress-has-the-votes-to-pass-federal-marijuana-reform-top-house-democrat-says/https://norml.org/blog/2026/04/22/poll-most-americans-support-making-marijuana-legal-nationwide-opinions-shaped-by-personal-experience/https://www.marijuanamoment.net/tennessee-lawmaker-calls-for-special-session-focused-on-medical-marijuana-as-its-federally-reclassified-under-trump/https://www.marijuanamoment.net/federal-marijuana-rescheduling-announced-by-department-of-justice-months-after-trump-executive-order/https://mmapplication.diversion.dea.gov/https://ganjapreneur.com/report-indiana-residents-spend-about-2b-on-cannabis-annually-despite-prohibition/https://www.marijuanamoment.net/house-passes-farm-bill-including-hemp-provisions-but-without-delaying-thc-product-ban-scheduled-for-this-year/https://www.marijuanamoment.net/gop-led-congressional-committee-votes-to-block-marijuana-rescheduling-defying-trump/https://themarijuanaherald.com/2026/04/global-cannabis-market-projected-to-reach-148-9-billion-by-2031/https://mjbizdaily.com/news/how-mso-terrascend-is-leading-the-cannabis-industry-forward/615734/

https://vimeo.com/1188884054?share=copy&fl=sv&fe=ci https://www.currentfederaltaxdevelopments.com/podcasts/2026/5/3/2026-05-04-treasury-previews-upcoming-280e-medical-marijuana-guidance This week we look at: Reasonable Cause Relief Under the Small-Corporation Provision for Form 5472 Penalties Extending the Statute of Limitations for Disallowed ERC Claims Legislative Update: House Passes Comprehensive Tax Administration and Relief Bills Anticipated IRS Guidance Following the Rescheduling of Medical Marijuana Analysis of the New Dyed Fuel Excise Tax Refund Regulations Under Section 6435 Executive Order on Retirement Savings and Its Interaction with IRC Section 6433

Treasury and IRS previews medical marijuana Section 280E guidance upcoming, the House passes 9 bipartisan tax bills, ERC statute of limitations extension guidance for refund claims and more

This week we look at: Reasonable Cause Relief Under the Small-Corporation Provision for Form 5472 Penalties Extending the Statute of Limitations for Disallowed ERC Claims Legislative Update: House Passes Comprehensive Tax Administration and Relief Bills Anticipated IRS Guidance Following the Rescheduling of Medical Marijuana Analysis of the New Dyed Fuel Excise Tax Refund Regulations Under Section 6435 Executive Order on Retirement Savings and Its Interaction with IRC Section 6433

Licensed medical cannabis has officially moved from Schedule I to Schedule III, but most operators still don't fully understand what changed, what didn't, and where the real risks and opportunities are. In this episode of Cultivation Elevated, host Michael Williamson sits down with cannabis attorney Christine Seney for a no-fluff breakdown of what rescheduling actually means on the ground, financially, operationally, and strategically.Christine works directly with MSOs, investors, and executive teams on licensing, compliance, deal structure, and capital strategy across multiple state markets. This is not outside commentary. This is real-time legal strategy.Timestamps:0:00 Introduction1:44 The most costly misconception operators have about Schedule III2:23 Medical vs. adult use: an expensive distinction3:54 Is this a tax issue, a compliance issue, or both?4:03 What MSO CFOs should be doing right now around 280E4:26 The 60-day DEA filing window explained5:16 Biggest missed opportunities in the next 6 to 12 months5:49 Import/export opportunities and FDA recognition6:13 Pharma partnerships and health insurance coverage for patients7:19 Banking, capital access, and legitimizing the industry8:47 Uplisting, credit card processing, and reducing transaction friction9:32 Why insurance coverage for medical patients would be a game changer10:01 Michael's 18 years as an operator and the real cost of medical cannabis therapy11:14 Does rescheduling actually change enforcement risk?11:30 Why DEA enforcement is coming and what it will look like13:10 How federal and state agencies work together on enforcement (Florida example)13:45 What has NOT changed that people think has14:37 IRS guidance still pending, travel caution still applies15:45 The "meaningful domino" analogy16:05 Winners and losers of rescheduling17:06 The CHAMPS case and mixed-license businesses18:27 Why new entrants have a strategic advantage right now19:13 Florida as a case study: medical-only, vertical integration, capital intensity20:46 Could Schedule III actually hurt parts of the cannabis industry?21:28 Big tobacco, big alcohol, and consolidation risks22:33 The craft operator opportunity and why smaller players can still win23:08 GMP, FDA oversight, and pharmaceutical standards coming to cultivation24:27 ASTM cannabis standards and what operators should be watching24:38 The next 3 legal and regulatory dominoes to watch25:15 Adult use descheduling, cartel policy, and the political path forward25:46 Hemp vs. cannabis and whether the two sides eventually collapse together26:23 Closing thoughtsKey topics covered: Cannabis rescheduling, Schedule III cannabis, 280E tax reform, DEA registration, medical marijuana compliance, MSO strategy, cannabis investment, GMP cannabis, FDA cannabis, cannabis banking, SAFE Banking, cannabis enforcement, cannabis legalization, hemp vs cannabis regulation, cannabis tax planning, multi-state operatorsGuest: Christine Senne is a cannabis attorney at Grossman, Roopnarine & Bayó, LLC, where she focuses on regulatory strategy, compliance, and complex business structuring across multiple state markets. She advises operators, investors, and executive teams on navigating licensing, enforcement risk, multi-state expansion, and capital strategy in one of the most highly regulated industries in the country.Christine is known for translating complex legal and regulatory frameworks into clear, practical guidance that operators can execute against. Her work sits at the intersection of law, policy, and real-world operations, making her a trusted advisor to companies scaling in dynamic and often uncertain environments.With the recent shift to Schedule III, Christine is actively working with clients to interpret and respond to this regulatory change in real time, providing critical insight into both the immediate implications and long-term strategic considerations for cannabis operators.Connect With PippPipp Horticulture Website - https://pipphorticulture.com/Pipp Horticulture YouTube - https://www.youtube.com/channel/UC4nNnNCiwS5k5GX7BaXIrbAPipp Horticulture - Facebook - https://www.facebook.com/pipphorticulturePipp Horticulture Instagram - https://www.instagram.com/pipphorticulture/Pipp Horticulture LinkedIn - https://www.linkedin.com/company/18333737/Pipp Horticulture Pinterest - https://www.pinterest.com/pipphorticulture/

We're back with the most anticipated episode of the year! In this year end financial review episode we are joined by our friend Nick Gastevich (aka CannaVestments) who is a long time private and public cannabis investor.In this Financial Review we cover - The biggest opportunity in Cannabis right now- Current market, hemp, portfolio sizing and which stocks we're currently buying- Cash flow, future growth & 280E benefits- Thoughts on MSOs valuations; financial metrics; balancing positives and negativesThanks to Nick for joining us and sharing his detailedanalysis as always!Connect with Nick:Twitter - ⁠⁠⁠⁠https://twitter.com/CannaVestments⁠⁠⁠⁠LinkedIn - ⁠⁠⁠⁠https://www.linkedin.com/in/nicholas-gastevich-75841346/⁠⁠⁠⁠Family Office Website - ⁠⁠⁠⁠https://www.vginvests.com/ ⁠

https://vimeo.com/1186533175?share=copy&fl=sv&fe=ci https://www.currentfederaltaxdevelopments.com/podcasts/2026/4/25/2026-04-27-no-more-280e-for-state-legal-medical-cannabis-businesses This week we look at: Tax Implications of the Rescheduling of State-Licensed Medical Marijuana Disallowance of COVID-19 Leave Credits: A Review of Substantiation and Trade or Business Requirements Substantiation, Entity Indebtedness, and Business Expense Deductibility: An Analysis of the Simmons Case The Tenth Circuit Codifies the Reach of the Economic Substance Doctrine Over Mechanical Statutory Compliance Treatment of Loyalty Rewards Program Funds and the Claim of Right Doctrine Valuation and Penalty Controversies in Estate Tax Examinations

Send us Fan MailThe hosts discuss what they describe as a major bulletin that medical marijuana is now legal nationwide when compliant with state licensing, tying it to a DOJ executive action by Acting Attorney General Todd Blanche and U.S. treaty obligations that would require a government monopoly over medical cannabis. They react to 4/20, YouTube channels being yanked for on-air smoking, and update progress on opening their Pekin, Illinois dispensary while noting Illinois “social equity” status helped with licensing but not loans, creating urgent debt. They outline how rescheduling was split into two lanes, reference OLC reasoning under CSA 811(d), anticipate lawsuits and resumed hearings (June 29), and argue IRC 280E may be retrospectively disallowed around 2023. They also debate hemp loopholes, “full spectrum CBD,” checkpoints/transport issues, employment drug tests, home grow under state law, and emphasize freeing incarcerated people and building coherent cannabis rules.00:00 Medical Legalization Shock00:09 Show Intro and QR00:25 Illinois Dispensary Update01:18 420 and Channel Strikes02:28 Why Nothing Changed Yet03:01 DOJ Executive Action Deep Dive06:51 Treaty Monopoly Explained07:56 Farm Bill Hemp Loopholes09:14 Full Spectrum CBD Debate12:53 No Smoking and Creator Risks14:43 Rescheduling Precedent Talk16:51 Illinois Loan and Lawsuit Math22:17 280E Tax Fallout25:14 Hearing Restart June 2926:19 Checkpoints and Federalism27:20 Rescheduling Reality Check27:36 Interstate Transport Risks29:10 420 Culture and Protest31:42 Medical Model Expansion34:42 Hemp Loopholes and Safety38:47 Workplace and Drug Tests41:18 Policy Memos and Politics43:47 Homegrow and State Compliance50:55 Wrap Up and What's Next52:19 Sponsor Collateral BaseSupport the showGet our newsletter: https://bit.ly/3VEn9vu

Send us Fan MailTom Howard of Cannabis Legalization News analyzes Acting Attorney General Todd Blanche's 33-page final order (signed April 22, published April 23) that creates a narrow, treaty-based “Schedule III” path under CSA §811(d)(1) to comply with the 1961 Single Convention. The order places two categories into Schedule III: FDA-approved marijuana drugs and marijuana covered by qualifying state medical marijuana licenses, while adult-use and other unlicensed/bulk marijuana remain Schedule I. Howard explains how DOJ bypassed the usual §811(a)/(b) hearing process, cites HHS findings on abuse potential and withdrawal, and ties the move to treaty controls like quotas, registration, recordkeeping, and a government purchase/resale mechanism. He discusses DEA registration, research access to state medical products, 280E mentions, and forecasts legal challenges by Smart Approaches to Marijuana and Torridon Law amid the ongoing broader rescheduling docket.00:00 Schedule Three Shockwave01:14 Order Overview and Oddities03:15 Treaty Based Rescheduling05:22 Why Medical Only07:38 Two Lane Schedule Three10:17 HHS Science and Abuse Data13:22 Bulk Marijuana Stays Schedule One16:29 DEA Rules and Compliance19:47 Research Access and 280E21:08 Regulatory Analysis and Definitions24:54 Naturally Derived THC Language25:37 Lawsuits and What Comes Next30:13 Wrap Up and SubscribeSupport the showGet our newsletter: https://bit.ly/3VEn9vu

DEA rescthedules state-legal medical marijuana, but recreational cannabis stays on Schedule III (and 280E issues continue for those businesses), Seventh Circuit finds claim of right can be used to exclude income from taxation and more.

This week we look at: Tax Implications of the Rescheduling of State-Licensed Medical Marijuana Disallowance of COVID-19 Leave Credits: A Review of Substantiation and Trade or Business Requirements The Tenth Circuit Codifies the Reach of the Economic Substance Doctrine Over Mechanical Statutory Compliance Substantiation, Entity Indebtedness, and Business Expense Deductibility: An Analysis of the Simmons Case Treatment of Loyalty Rewards Program Funds and the Claim of Right Doctrine Valuation and Penalty Controversies in Estate Tax Examinations

High Growth, Higher Risk: The Business of Cannabis w/ Melissa Diaz of Highrock Accounting - AZ TRT S07 EP07 (289) 4-12-2026       What We Learned This Week Cannabis Companies Are Taxed on Gross Margin Because of 280E, they can't deduct ordinary business expenses — creating massive tax burdens. Federal Classification Drives Everything Schedule I status impacts taxation, banking, regulation, and investor appetite. Many Companies Are Playing Legal Offense Some are challenging 280E aggressively, treating unpaid taxes as a strategic risk. Licensing Structure Determines Success Limited-license states create stronger economics. Unlimited states create margin compression. Consolidation Is Coming Stronger, vertically integrated, mid-sized operators are likely to dominate by 2026. Guest: Melissa Diaz https://www.highrock.co/ https://www.linkedin.com/in/melissa-k-diaz-cpa-10215623/ Melissa Diaz is a powerhouse at the intersection of accounting, strategy, and tech. As Co-Owner and CRO of High Rock Accounting (and co-founder of Rebel Rock PC, now High Rock), she leads with precision on everything from cash flow and budgeting to due diligence and audit readiness. At High Rock she helps businesses harness cutting-edge technology to make smarter, faster, fully compliant financial decisions both day-to-day and long-term. With an expertise in Cannabis and the Technology industry, Melissa's mission is clear: empower businesses to stay competitive, compliant, and efficient in high-pressure, high-growth environments. Whether she's solving complex reporting challenges or decoding 280E, Melissa brings charisma, clarity, and confidence to the table every time.      

In this episode of the Cannabis Accounting Podcast, host Raymond Guns sits down with Jim Ickes, Partner at Frantz Ward and one of the most experienced cannabis and hemp attorneys in the country, to break down the legal and financial reality facing the hemp beverage industry right now — and why the longer arc still points toward normalization.Jim has been practicing law for 26 years, working in cannabis for a decade, and has advised everyone from Ohio operators to the Greek Ministry of Agriculture on medical cannabis frameworks. Since 2023, hemp beverages have been his primary focus — which means he had a front-row seat to both the boom and the regulatory gut punch that followed.Jim breaks down:

Politics is a dirty business. Sometimes being feared is the influence you need because access is not the problem. Politicians say "we'll take care of this." Gretchen Gailey has a different approach: stab them in the back, push them down the stairs, and take credit for the fall. It's time to put fear behind cannabis. She spent 20 years on Capitol Hill. She's watched cannabis show up once a year for fly-ins, throw money at the wrong politicians, and wonder why nothing changes. This episode breaks down why incrementalism is the only path, why banking matters more than you think, and why the industry needs to stop picking out curtains when it hasn't built a basement. This week we sit down with Gretchen Gailey: Stab them in the back politics Curtains before basement problem Project Champion playbook   Timestamps: 00:00 - The industry's fundamental misunderstanding about Washington politics 02:35 - Challenges with incrementalism versus desire for rapid change 04:47 - Supporting pro-cannabis politicians like Cynthia Loomis 06:45 - The role of education and public awareness campaigns 10:06 - Building a basic regulatory foundation: banking, safe products, and rescheduling 13:23 - The limitations of state-led models and the need for federal coordination 15:50 - The importance of transparency and federal standards for consumer safety 18:43 - The influence of political operatives and the importance of direct advocacy 22:51 - Using industry tools and data to inform policy and educate policymakers 26:15 - The significance of Congressional engagement and how to make cannabis an urgent issue 30:10 - The importance of political will and executive orders in advancing reform 34:40 - The disconnects within Washington and how industry can better influence policy 37:19 - Opportunities in leveraging symbolism like Veterans issues and Congressional events 41:14 - The disconnect between access and influence, and how to effectively make the case 44:40 - The necessity of creative strategies, public pressure, and celebrity involvement 50:21 - Successful stories: case of Cory Booker and the impact of direct constituent advocacy 52:16 - Final thoughts: how to stay engaged and educate the industry and policymakers Summary:  In this episode, Gretchen Gailey shares over 20 years of experience navigating Washington's complex cannabis legislation. We explore how industry players can effectively engage with policymakers, the importance of foundational regulations, and strategies to accelerate federal progress on cannabis reform. Guest Links: https://www.linkedin.com/in/gretchengailey https://projectchampion.org/ https://x.com/GretchenGailey Our Links Bryan Fields on Twitter Kellan Finney on Twitter The Dime on Twitter Extraction Teams: Want to cut costs and get more out of every run? Unlock hidden revenue by extracting more from the same input—with Newton Insights. At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry. The Dime is a top 5% most shared  global podcast The Dime is a top 10 Cannabis Podcast  The Dime has a New Website. Shhhh its not finished.

Send us Fan MailThe hosts discuss cannabis legalization frustrations and preview stories for the week ending March 15, 2026, led by a tax court case tied to roughly $1.6B in MSO 280E-related liability, where the U.S. argues cannabis businesses fall “within the meaning” of Schedule I/II for 2016–2017 tax years, despite the ongoing rescheduling push. They note a Ninth Circuit decision that the dormant Commerce Clause does not apply to cannabis, contrasting with East Coast rulings and a continuing circuit split after the Supreme Court declined review. State updates include Texas's March 31 ban on smokable hemp/THCA flower sales, Tennessee “pot for potholes” messaging, Virginia's new micro-vertical licensing framework and regulator setup, Alabama's medical rollout delays due to litigation, Florida's ballot initiative setbacks and political hypocrisy, and Verano's $195M loan amid ongoing MSO expansion.Support the showGet our newsletter: https://bit.ly/3VEn9vu

Scot Crow and Benjam Sobczak of Dickinson Wright tare back this week to discuss the industry's significant $6 billion debt crisis and the necessary survival strategies for compromised companies. The debt crisis is separate from 280E tax liabilities, rooted in market volatility (like the sharp price drop in Michigan) and poor financial projections made by both operators and lenders. For operators facing default, the critical advice is to make an early decision: either cooperate with the lender's efforts or fight, recognizing that fighting carries the high risk of multi-million dollar personal judgment liens due to personal guarantees (PGs) on the loans. Experts stressed that honesty and transparency are paramount; struggling companies must openly communicate their financial position with existing lenders and be upfront with initial equity investors about the likely washout of their investment.Advertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

Recorded live at @MJBizCon 2025, this episode of Cannabis Tech Talks, hosted by Mary Jane Gibson and sponsored by @SHOPLINE in association with ICBC, features @Brett Harris, founder and CEO of LuvBuds. Known as the “King Bong,” Harris built a company now supplying roughly 30% of American dispensaries by helping retailers navigate federal tax code 280E through ancillary product sales that unlock legal overhead deductions.From the show floor, Harris breaks down the industry's current “trough period,” marked by consolidation, debt-heavy MSOs, and mounting pressure on independent operators.WEBSITE: https://cannatechtoday.com/Make sure to follow our other social media platforms to stay up-to-date on all things Cannabis & Tech Today.https://twitter.com/cannatechtodayhttps://www.facebook.com/CannaTechTodayhttps://www.instagram.com/cannatechtoday

On this episode of the Kaya Cast Podcast, host Tommy Truong sits down with Lucas Gould, co founder and CEO of Spendr, to unpack breaking cannabis news and what it means for operators across the country. They dive into the federal move to reschedule cannabis to Schedule III, its potential impact on medical vs recreational markets, banking, 280E tax relief, research funding, interstate commerce, and what rules might follow as the dust settles. Will state lines stay drawn or start to blur? How might federal oversight influence medical cannabis programs? Then the conversation shifts to Spendr, the cannabis payments and loyalty platform. Lucas explains how Spendr started to solve cash payments and has evolved into turning payments into a retention channel. Learn how end users sign up, fund a digital wallet, and pay with a tap or QR code in store, and how Spendr automatically retargets customers with personalized offers from the dispensaries they shop at. See how Spendr helps 200 plus locations in 13 markets drive loyalty, while being POS agnostic and revenue positive for merchants. The episode also covers growth, hiring, maintaining quality during rapid expansion, and the importance of brand, employee training, and exceptional customer experience in building lasting loyalty. Whether you're a dispensary operator, investor, or supplier, you'll come away with practical ideas to boost retention, streamline payments, and position your brand for a post regulatory change cannabis economy. Find out more about Spendr at:https://www.spendr.com/business?utm_source=linkedin&utm_medium=organic&utm_campaign=linkedin-page-buttonhttps://www.linkedin.com/in/lucas-gould-b67b8311b/https://www.linkedin.com/company/getspendr/about/ 00:00 Breaking News: Trump Admin Moves to Reschedule Cannabis to Schedule III01:11 What Schedule III Could Mean: 280E Relief, Research, and the Medical vs. Rec Gray Area04:23 Banking & Capital Access: How Compliance Burdens Might Ease Under Schedule III05:24 Interstate Commerce Reality Check + Pharma Cannabinoid Opportunities07:05 Meet Lucas & Spendr: Cashless Payments + Loyalty Platform for Dispensaries10:19 The Original Pain Point: Fixing Cash Payments, Then Evolving Into Retention12:23 Turning Payments Into a High-Intent Marketing Channel14:05 Winning Attention: Relevancy Over Spam (and Why Utility Beats “Marketing Apps”)18:44 How Spendr Works End-to-End: App Setup, QR Pay, Rewards, and Merchant Flow20:57 Repeat Customers on Autopilot: Enrollment, Retargeting, and Multi-Store Behavior23:56 Marketplace vs. Inventory: What Spendr Tracks (and What It Doesn't)24:36 How Spendr Works at Checkout (Online vs In-Store QR Pay)25:15 Merchant Fees & Why Spendr Sells Loyalty, Not Payments26:56 Marketplace vs Revenue Channel: Subsidized Prices & More Repeat Visits28:57 The Future of Dispensary Loyalty: Experience, Communication & Brand Promise34:07 Why Budtenders Matter: Training, Reviews, and the Personal Nature of Cannabis35:26 Cannabis Buying Is Advisory: Mood, Variety, and Always Trying Something New39:48 2026 Milestones: Scaling to More States Without Losing Quality Support44:49 Founder Mindset: Infinite Problem-Solving, Medical Roots, and Staying Alive47:11 Where to Find Spendr + What's Next (Wrap-Up)cannabis rescheduling, Schedule III cannabis, federal cannabis news, cannabis legalization update, 280E tax relief, cannabis banking reform, SAFE Banking Act, cannabis compliance, cannabis regulations, federal cannabis policy, medical vs recreational cannabis, cannabis market trends, interstate cannabis commerce, cannabis research funding, DEA rescheduling, cannabis tax reform, dispensary operations, dispensary retention strategies, cannabis payments platform, cashless cannabis, cannabis digital wallet, QR code payments cannabis, tap to pay cannabis, cannabis fintech, Spendr, Lucas Gould, Tommy Truong, Kaya Cast Podcast #kayacast #cannabis #tips #dispensaries #business #podcast

Why are cannabis businesses still failing- even as demand grows? Sara  talks 280E, rescheduling, and survival strategies with Darren Gleeman of MBO Ventures. A must-listen from MJBizCon. [Ep 192]

The effects of the change in the federal stance on the scheduling status of cannabis may have many impacts on what insurers and those who service the industry … Read More » The post EP. 104: 280E Is Key to Understanding Impact of Federal Shift on Cannabis appeared first on Insurance Journal TV.

The effects of the change in the federal stance on the scheduling status of cannabis may have many impacts on what insurers and those who service the industry … Read More » The post EP. 104: 280E Is Key to Understanding Impact of Federal Shift on Cannabis appeared first on Insurance Journal TV.

The effects of the change in the federal stance on the scheduling status of cannabis may have many impacts on what insurers and those who service the industry … Read More » The post EP. 104: 280E Is Key to Understanding Impact of Federal Shift on Cannabis appeared first on Insurance Journal TV.

In this episode of Cannabis Unlocked, Jordan Youkilis is joined by Joe Bayern, newly appointed CEO of MM Brands Inc., following their acquisition of BellRock Brand's portfolio.Joe shares his career path from consumer packaged goods and beverage turnarounds to senior leadership roles across cannabis, including taking Indus Holdings public and scaling Curaleaf through its most aggressive growth phase. Drawing on experience across both vertically-integrated operations and brand-led platforms, he explains why trust, efficacy, consistency, and execution, not simply scale,  will define the industry's next chapter.The conversation covers the opportunity Mary's Medicinals and Dixie Brands have to stand out as national brands. With industry normalization beginning Schedule III momentum, 280E relief, and evolving regulation could reshape distribution, banking, and consumer education. In closing, Joe and Jordan also discuss the future of cannabinoid research, product consistency, and building an omni-channel, asset-light brand model in a state-by-state market.Please enjoy the episode!

In this episode, we talk with Lee Generous, a wealth management expert. He helps cannabis founders plan for money, taxes, and their long-term future. Lee explains why cannabis owners face special challenges, like 280E taxes and limited access to banks and capital. He shares why Dope CFO Wealth Management was launched in 2023 to give cannabis business owners the same support big family offices provide.We explore why most business exits fail and what cannabis founders can do now to protect the value of their companies. Lee shows how good planning can lower stress, save taxes, and prepare owners for life after selling their business. He also talks about the personal side of money, like helping families plan for kids, health needs, and major life changes.Lee shares why he is hopeful about the future of cannabis with more states legalizing and federal reforms getting closer. He also explains how the wealth industry is changing, with more fee-only advisors who put clients first. This episode gives simple steps, real lessons, and strong advice for anyone building or investing in a cannabis company.*Disclaimer: The views expressed in this episode are for informational and educational purposes only and do not constitute individualized investment, tax, or legal advice. Lee Generous is a co-founder of Dope CFO Wealth Management LLC, a fee-only, MA-registered investment adviser. Nothing in this podcast is an offer or recommendation to buy or sell any security or to participate in any investment strategy. All investments involve risk, including possible loss of principal. Advisory services are offered only where Dope CFO Wealth Management LLC is properly registered or exempt from registration, and listeners should consult their own professional advisers before making any financial decisions.

Julian Lin runs Best of Breed Growth Stocks and discusses his high conviction pick: IIPR (0:35). Reasons to be bullish (3:00). IIPR's dividend safety (7:20) 280E taxes and cannabis rescheduling (12:15). Is legalization good for multi-state cannabis operators? (16:30) Risks to REITs (21:00). Red and green flags for management (29:00). How investors should think about valuation (37:05).Show Notes:Innovative Industrial: Cannabis Rescheduling Changes Everything - 16% Yield Is A Conviction BuyCannabis Investing In The Trump EraRead our transcriptsFor full access to analyst ratings, stock and ETF quant scores, and dividend grades, subscribe to Seeking Alpha Premium at seekingalpha.com/subscriptions

Higher Exchanges is presented by Flowhub. Following the federal Executive Order to move cannabis from Schedule I to Schedule III, the cannabis industry may be entering the early stages of a new M&A cycle.In this episode of Higher Exchanges, Jesse Redmond and Morgan Paxhia are joined by Dai Trong, Managing Director at Arlington Capital Partners, to discuss how rescheduling could accelerate consolidation, unlock capital, and reshape strategic behavior across the sector.After years of contraction, oversupply, margin pressure, and 280E tax burdens, cannabis M&A is beginning to re-emerge—starting with distressed and opportunistic deals by better-capitalized operators.We cover:What Schedule III changes most for cannabis M&AWhere we are in the current consolidation cycleWhy some operators are moving now while others remain cautiousRecent real-world deal activity across California and beyondWhat still needs to happen for larger strategics and capital to re-engageFinally, we close with Dai offering M&A tips to both operators and investors!

President Donald Trump has signed an executive order to direct the federal government to move cannabis from Schedule I to Schedule III — and this single change could dramatically reshape the financial future of cannabis companies.From an accounting and tax perspective, this is one of the most important developments the industry has ever seen.If this rescheduling is finalized, many cannabis businesses could:See massive relief from 280E- Unlock significantly higher cash flow- Become far more attractive to investors- And in some cases, become up to 7.5x more valuable overnightIn this video, we break down:- What Schedule III actually changes for cannabis companies- How accounting treatment and tax planning could shift- Why free cash flow & and valuations may change dramatically- What CPAs, accountants, and financial professionals should be preparing for nowThis is a practical, finance-first breakdown of what this means for companies operating in the cannabis industry and the professionals advising them

Marijuana rescheduling proposed regulation finalization moves back into the fast lane after a year, which would remove §280E as an issue for cannabis businesses and two update Fact Sheets for OBBBA changes.

Utah's cannabis rules have more plot twists than a Netflix drama, and most people are one viral headline away from doing something dumb by accident. So we brought JD Lauritzen, The Leafy Lawyer, back on to translate the chaos into plain English. We talk hemp, the “loophole” argument, rescheduling, taxes that crush businesses, and why “legal” is a word people throw around way too casually.What we get intoThe hemp-derived mess, why it keeps whiplashing, and why “it's legal again” posts are usually missing the pointThe scary part, timing, JD calls out that “next November” is a real inflection point unless something changes, and the implications of hemp becoming illegal againThe “loophole” debate, JD's take is blunt, it was never a loophole, it was the text, plus how regulation failed to keep upRescheduling talk, why moving to “schedule three” matters, and why it still doesn't magically fix everything overnightThe business killer most consumers never hear about, 280E taxes, and why even good operators get strangled by the mathThe potency fight, what “limit potency” sounds like in a hearing room, and why enforcement is way messier than people thinkBig takeawaysIf a headline makes you want to panic buy, it's probably selling clicks, not clarityUtah changes tend to be slow and surgical, not one big “everything is illegal now” momentHemp and medical get mixed up constantly, but policy treats them like different animalsRescheduling can help, but taxes and timelines are where reality lives“Limit potency” sounds simple until you try to enforce it in the real worldConnect with JD - https://www.instagram.com/the_leafy_lawyer/Save on Dr Dabber with Code: Cannabisschool10Save on Storz & Bickel with Code : CannabisschoolSave on Santa Cruz Shredder with Code: CSP10Save on Bomb Erigs with Code: CSPScore 100 on your test

Send us a textBREAKING NEWS: Donald Trump is expected to make a historic announcement regarding a Marijuana Executive Order today at 1:30 PM ET. Join cannabis lawyer Thomas Howard and Miggy 420 LIVE on Cannabis Legalization News for real-time legal analysis of this potential rescheduling event.In this live stream, we cover:The Announcement: Full breakdown of Trump's executive order on weed and what the text actually says.Legal Reality: Does this move marijuana to Schedule 3? What happens to 280E taxes immediately?Business Impact: How this affects the cannabis industry, MSOs, and marijuana stocks right now.Next Steps: What federal legalization looks like moving forward and what Congress must do next.Get the facts without the hype. This is your go-to source for cannabis business legal strategy and industry insights.want to start your own podcast?  Try StreamYard.Want to create live streams like this? Check out StreamYard: https://streamyard.com/pal/d/58220373...Support the showGet our newsletter: https://bit.ly/3VEn9vu

On December 17, as fresh reports suggested cannabis could be rescheduled any day, I sat down with Jordan Davidson, government affairs director at Smart Approaches to Marijuana (SAM), to hear the case against moving cannabis from Schedule I to Schedule III. We revisit how the rescheduling process started, review President Trump's recent comments, and dig into SAM's core concerns, including 280E tax implications, messaging to young people, public safety, and what rescheduling does and does not change. We also get into a brief debate around DOT testing and “safety carveouts,” plus a broader question that has been on my mind: if cannabis companies want wider access and expansion, why did so many either support a hemp ban or stay quiet as it moved forward? Watch video version and read full show notes here: https://thecolememo.com/2025/12/17/e244/

In Episode 242, Cole breaks down President Trump's latest comments on cannabis reclassification, comparing them to his earlier remarks from August and zooming in on what changed, especially the new emphasis on research. With reports swirling about possible timing, Cole reacts to the broader rumor mill, pulls in chatter from The Dales Report, and highlights how different corners of the industry are reading the tea leaves. Then the show opens up into a real conversation: rescheduling vs descheduling, the Farm Bill angle, 280E tax pressure, and the ongoing debate over whether state markets would survive a Schedule III world. Plus, a call-in from Brian brings the “people before profits” argument front and center, with a clear message that access matters more than labels like “hemp” or “marijuana.” Watch video version and read full show notes here: https://thecolememo.com/2025/12/15/e242/

The recent closing of the hemp loophole is set to bring massive changes to the $30 billion hemp industry. For years, hemp-derived THC products thrived in a legal gray area, but now the federal government has set a one-year deadline to end the sale of most intoxicating hemp products.This shift will create new challenges for hemp businesses as they adapt to stricter regulations, but it also opens up opportunities for accountants to step in as trusted advisors during this critical transition.Join Andrew Hunzicker, CPA, along with leading cannabis tax attorneys Rachel Gillette and Jen Benda from Holland & Hart, as they break down the implications of the hemp loophole closure and what it means for accountants, cannabis businesses, and the broader industry.You'll learn:The immediate impact of the hemp loophole closure on businessesHow hemp businesses can navigate compliance and restructuringOpportunities in the evolving CBD and cannabis marketsKey financial challenges businesses will face in 2026Best practices for advising clients during this period of changeSupport the Fight Against 280E: The New Mexico Top Organics case could fundamentally change how 280E applies to cannabis businesses. You can help strengthen the case by contributing to the amicus brief being filed by cannabis industry groups. Don't miss this essential discussion with Andrew Hunzicker, Rachel Gillette, and Jen Benda on one of the most significant regulatory changes in years!

In this episode, we sit down with Micah Anderson, CEO of LEEF Brands (CSE: LEEF | OTCQB: LEEEF), to break down the company's Q3 2025 financial results and what's driving its turnaround story.LEEF delivered a standout quarter with revenue up 24% year-over-year to $8.4M, gross margins doubling to 45%, and the company generating positive adjusted EBITDA and free cash flow for the first time. We discuss the key drivers behind that performance — from the first successful harvests at Salisbury Canyon Ranch in California to the rapid launch of LEEF's extraction lab in New York.Topics we cover:• The execution behind Salisbury Canyon Ranch and New York — LEEF's two 2025 strategic goals — and how they are reshaping cost structure and margins.• The operational levers behind a 23-point margin expansion: how much came from vertical integration vs. new market mix.• How LEEF is maintaining cost discipline with operating expenses down 12% YoY while growing topline performance.• The company's approach to managing 280E taxes and its stance on accruing vs. paying UTP.• Why LEEF added Bitcoin to its corporate treasury, and how Micah views Bitcoin allocation versus other growth investments like expansion or scaling SCR.• Plans for the next phase: expanding cultivation at Salisbury Canyon Ranch to 187 acres, scaling production in New York, and evaluating new state entries every 12–24 months.After Micah joins, we broaden the discussion with a look at the Q3 earnings season across cannabis, including Verano and Jushi. We dig into trends like margin compression, limited catalysts until 2026+ in key states, and how efficiency and vertical integration are separating strong operators from those treading water.A grounded, data-driven discussion on execution, cost control, and strategy in a tough market — plus a look at where real growth may come next.

Send us a textIn this episode of Cannabis Legalization News, hosts delve into the latest happenings in the cannabis industry and policy. The show highlights the intricacies of the ongoing government shutdown and its impact on hemp policy, touches on daylight savings time adjustments, and examines GOP Senator Rand Paul's stance on hemp versus THC policy. The heated debate around IRC 280E tax and its ramifications for cannabis dispensaries is dissected in detail, along with discussions about the fight for cannabis legalization and the loopholes being exploited in the hemp industry. Special guest CPA Justin sheds light on the petition against 280E in the tax court, potential tax refunds, and strategies for businesses to navigate the complex cannabis tax landscape. They also touch upon upcoming events like MJ BizCon and provide updates on their own dispensary opening in Pekin, Illinois. Overall, this episode is a comprehensive guide to the current cannabis policy climate.00:00 Welcome and Introduction00:43 Government Shutdown and Hemp Policy01:06 Daylight Savings and Rand Paul Controversy02:23 Hemp vs. Cotton: The Industrial Debate03:11 Legal Loopholes and Hemp Industry06:27 Tax Policy and IRC 280E10:50 Federal and State Legal Complexities14:47 Cannabis Business Challenges16:52 Upcoming Guest and Industry Drama32:27 Government Shutdown and Cannabis32:29 Hemp vs. Cannabis: Personal Experiences34:16 Legal and Tax Implications of Cannabis36:07 Court Cases and Tax Strategies36:38 Federal Rescheduling and Industry Impact39:47 Class Action Lawsuits and Government Accountability45:46 MJ Biz Conference and Industry Networking49:05 Cannabis Regulation and Compliance Challenges59:01 Closing Remarks and Future OutlookSign up for our newsletter: https://bit.ly/3VEn9vu Support the showGet our newsletter: https://bit.ly/3VEn9vu

In this episode of Cannabis Unlocked, Aaron Miles, Chief Investment Officer of Verano Holdings, joins Jordan Youkilis, Founding Partner at KEY Investment Partners, to share his path from publishing into cannabis. The two dive into what makes Verano different from other cannabis operators. Aaron kicks off with insights into the challenges of cannabis finance, attracting institutional capital, and the potential impact up-listing could have for public cannabis companies.Next they dive into today's market themes: shifting M&A activity, price compression, competition from intoxicating hemp, and state-level opportunities. The two close with perspectives on rescheduling, 280E, the cultural role of cannabis, the future of psychedelics, and how Verano is positioning itself to stay ahead of capital markets.Please enjoy the episode!

Tax Court issues decision on handling W-2 wages for QBI purposes for cannabis business, "placed in service" definition clarified for pre-IRA electric vehicle credits, and more developments.

The U.S. government is considering one of the biggest cannabis policy shifts in decades—moving marijuana from Schedule I to Schedule III under federal law. If approved, this change could ease tax burdens, open the door to banking access, accelerate mergers and acquisitions, and reshape the industry's growth trajectory. In this episode, Kathy Fettke breaks down what federal reclassification could mean for investors, including the potential end of IRS rule 280E, how capital might flow back into cannabis businesses, and the impact this could have on real estate investors. She also explains what this shift would not do—like full legalization—and the implications for research, regulation, and market consolidation. LINKS: JOIN RealWealth® FOR FREE https://realwealth.com/join-step-1  FOLLOW OUR PODCASTS Real Wealth Show: Real Estate Investing Podcast https://link.chtbl.com/RWS